nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylate-sodium—PTGS1—kidney cancer	0.475	0.636	CbGaD
Salicylate-sodium—PTGS2—kidney cancer	0.271	0.364	CbGaD
Salicylate-sodium—PTGS1—Prostaglandin Synthesis and Regulation—ANXA4—kidney cancer	0.00186	0.0627	CbGpPWpGaD
Salicylate-sodium—PTGS2—Prostaglandin Synthesis and Regulation—ANXA4—kidney cancer	0.00148	0.0498	CbGpPWpGaD
Salicylate-sodium—Acetylsalicylic acid—TP53—kidney cancer	0.0013	0.223	CrCbGaD
Salicylate-sodium—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—KEAP1—kidney cancer	0.00112	0.0378	CbGpPWpGaD
Salicylate-sodium—PTGS2—Signaling mediated by p38-alpha and p38-beta—KRT8—kidney cancer	0.000988	0.0334	CbGpPWpGaD
Salicylate-sodium—PTGS1—Prostaglandin Synthesis and Regulation—ANXA2—kidney cancer	0.000976	0.0329	CbGpPWpGaD
Salicylate-sodium—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS1—kidney cancer	0.000819	0.0276	CbGpPWpGaD
Salicylate-sodium—PTGS2—Prostaglandin Synthesis and Regulation—ANXA2—kidney cancer	0.000775	0.0262	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcium signaling in the CD4+ TCR pathway—FOSL1—kidney cancer	0.000767	0.0259	CbGpPWpGaD
Salicylate-sodium—Magnesium salicylate—PTGS1—kidney cancer	0.000699	0.12	CrCbGaD
Salicylate-sodium—PTGS2—Overview of nanoparticle effects—PTGS1—kidney cancer	0.000642	0.0216	CbGpPWpGaD
Salicylate-sodium—Salsalate—PTGS1—kidney cancer	0.000594	0.102	CrCbGaD
Salicylate-sodium—PTGS1—Prostaglandin Synthesis and Regulation—ANXA1—kidney cancer	0.00055	0.0186	CbGpPWpGaD
Salicylate-sodium—PTGS2—Eicosanoid Synthesis—PTGS1—kidney cancer	0.000532	0.018	CbGpPWpGaD
Salicylate-sodium—Mesalazine—PTGS1—kidney cancer	0.000516	0.0888	CrCbGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOSL1—kidney cancer	0.000496	0.0167	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—ROS1—kidney cancer	0.000493	0.0166	CbGpPWpGaD
Salicylate-sodium—PTGS2—Signaling mediated by p38-alpha and p38-beta—MITF—kidney cancer	0.000483	0.0163	CbGpPWpGaD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000474	0.016	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—ACY1—kidney cancer	0.00046	0.0155	CbGpPWpGaD
Salicylate-sodium—PTGS2—Prostaglandin Synthesis and Regulation—PTGS1—kidney cancer	0.000445	0.015	CbGpPWpGaD
Salicylate-sodium—Acetylsalicylic acid—PTGS1—kidney cancer	0.000444	0.0765	CrCbGaD
Salicylate-sodium—PTGS2—Prostaglandin Synthesis and Regulation—ANXA1—kidney cancer	0.000437	0.0147	CbGpPWpGaD
Salicylate-sodium—PTGS2—Signaling mediated by p38-alpha and p38-beta—HSPB1—kidney cancer	0.000415	0.014	CbGpPWpGaD
Salicylate-sodium—PTGS2—Signaling mediated by p38-alpha and p38-beta—EIF4EBP1—kidney cancer	0.000415	0.014	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUNB—kidney cancer	0.000403	0.0136	CbGpPWpGaD
Salicylate-sodium—Magnesium salicylate—PTGS2—kidney cancer	0.000399	0.0688	CrCbGaD
Salicylate-sodium—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—kidney cancer	0.000395	0.0133	CbGpPWpGaD
Salicylate-sodium—Salicylic acid—PTGS1—kidney cancer	0.000365	0.063	CrCbGaD
Salicylate-sodium—PTGS2—S1P1 pathway—KDR—kidney cancer	0.000352	0.0119	CbGpPWpGaD
Salicylate-sodium—Salsalate—PTGS2—kidney cancer	0.00034	0.0585	CrCbGaD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—PTGS2—kidney cancer	0.00031	0.0105	CbGpPWpGaD
Salicylate-sodium—PTGS2—Arachidonic acid metabolism—PTGS1—kidney cancer	0.000296	0.00998	CbGpPWpGaD
Salicylate-sodium—Mesalazine—PTGS2—kidney cancer	0.000295	0.0508	CrCbGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUNB—kidney cancer	0.00026	0.00879	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—CD34—kidney cancer	0.000258	0.0087	CbGpPWpGaD
Salicylate-sodium—PTGS1—Eicosanoid Synthesis—PTGS2—kidney cancer	0.000257	0.00867	CbGpPWpGaD
Salicylate-sodium—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—kidney cancer	0.000254	0.00858	CbGpPWpGaD
Salicylate-sodium—Acetylsalicylic acid—PTGS2—kidney cancer	0.000254	0.0437	CrCbGaD
Salicylate-sodium—PTGS1—Biological oxidations—ALDH1A1—kidney cancer	0.000252	0.0085	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—EGR1—kidney cancer	0.000244	0.00822	CbGpPWpGaD
Salicylate-sodium—PTGS1—Arachidonic acid metabolism—CYP1A1—kidney cancer	0.00024	0.0081	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—SCARB1—kidney cancer	0.000239	0.00808	CbGpPWpGaD
Salicylate-sodium—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—kidney cancer	0.000222	0.0075	CbGpPWpGaD
Salicylate-sodium—Acetylsalicylic acid—ABCB1—kidney cancer	0.000216	0.0372	CrCbGaD
Salicylate-sodium—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—kidney cancer	0.000215	0.00725	CbGpPWpGaD
Salicylate-sodium—Salicylic acid—PTGS2—kidney cancer	0.000209	0.036	CrCbGaD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—kidney cancer	0.000204	0.00688	CbGpPWpGaD
Salicylate-sodium—PTGS2—S1P1 pathway—VEGFA—kidney cancer	0.000194	0.00653	CbGpPWpGaD
Salicylate-sodium—PTGS2—Arachidonic acid metabolism—CYP1A1—kidney cancer	0.000191	0.00643	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—SCARB1—kidney cancer	0.00019	0.00642	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—PTGS1—kidney cancer	0.000188	0.00635	CbGpPWpGaD
Salicylate-sodium—PTGS2—S1P1 pathway—MAPK3—kidney cancer	0.000183	0.00618	CbGpPWpGaD
Salicylate-sodium—Salicylic acid—ABCB1—kidney cancer	0.000178	0.0306	CrCbGaD
Salicylate-sodium—Diarrhoea—Vinblastine—kidney cancer	0.000176	0.000808	CcSEcCtD
Salicylate-sodium—Body temperature increased—Sorafenib—kidney cancer	0.000176	0.000807	CcSEcCtD
Salicylate-sodium—Abdominal pain—Sorafenib—kidney cancer	0.000176	0.000807	CcSEcCtD
Salicylate-sodium—Diarrhoea—Everolimus—kidney cancer	0.000176	0.000804	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Sunitinib—kidney cancer	0.000175	0.000803	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Vincristine—kidney cancer	0.000175	0.000803	CcSEcCtD
Salicylate-sodium—Pruritus—Erlotinib—kidney cancer	0.000175	0.000803	CcSEcCtD
Salicylate-sodium—Fatigue—Dactinomycin—kidney cancer	0.000175	0.000801	CcSEcCtD
Salicylate-sodium—Epistaxis—Capecitabine—kidney cancer	0.000175	0.000801	CcSEcCtD
Salicylate-sodium—PTGS2—S1P1 pathway—MAPK1—kidney cancer	0.000174	0.00588	CbGpPWpGaD
Salicylate-sodium—Flatulence—Paclitaxel—kidney cancer	0.000174	0.000797	CcSEcCtD
Salicylate-sodium—Pain—Dactinomycin—kidney cancer	0.000173	0.000795	CcSEcCtD
Salicylate-sodium—Anorexia—Vincristine—kidney cancer	0.000173	0.000792	CcSEcCtD
Salicylate-sodium—Dysgeusia—Paclitaxel—kidney cancer	0.000173	0.000792	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Gemcitabine—kidney cancer	0.000172	0.000788	CcSEcCtD
Salicylate-sodium—Oedema—Gemcitabine—kidney cancer	0.000172	0.000788	CcSEcCtD
Salicylate-sodium—Cardiac failure congestive—Doxorubicin—kidney cancer	0.000171	0.000783	CcSEcCtD
Salicylate-sodium—Infection—Gemcitabine—kidney cancer	0.000171	0.000783	CcSEcCtD
Salicylate-sodium—Dizziness—Vinblastine—kidney cancer	0.00017	0.00078	CcSEcCtD
Salicylate-sodium—Dizziness—Everolimus—kidney cancer	0.00017	0.000777	CcSEcCtD
Salicylate-sodium—Body temperature increased—Sunitinib—kidney cancer	0.000169	0.000776	CcSEcCtD
Salicylate-sodium—Abdominal pain—Sunitinib—kidney cancer	0.000169	0.000776	CcSEcCtD
Salicylate-sodium—Diarrhoea—Erlotinib—kidney cancer	0.000169	0.000776	CcSEcCtD
Salicylate-sodium—Hypotension—Vincristine—kidney cancer	0.000169	0.000776	CcSEcCtD
Salicylate-sodium—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—kidney cancer	0.000168	0.00568	CbGpPWpGaD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000168	0.00568	CbGpPWpGaD
Salicylate-sodium—Renal failure acute—Doxorubicin—kidney cancer	0.000168	0.000769	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Dactinomycin—kidney cancer	0.000167	0.000766	CcSEcCtD
Salicylate-sodium—Hepatitis—Capecitabine—kidney cancer	0.000166	0.000762	CcSEcCtD
Salicylate-sodium—Vision blurred—Paclitaxel—kidney cancer	0.000166	0.000762	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Gemcitabine—kidney cancer	0.000166	0.000762	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000166	0.00076	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Capecitabine—kidney cancer	0.000165	0.000758	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Sorafenib—kidney cancer	0.000164	0.000752	CcSEcCtD
Salicylate-sodium—Anorexia—Gemcitabine—kidney cancer	0.000164	0.000751	CcSEcCtD
Salicylate-sodium—Vomiting—Vinblastine—kidney cancer	0.000164	0.00075	CcSEcCtD
Salicylate-sodium—Dizziness—Erlotinib—kidney cancer	0.000164	0.00075	CcSEcCtD
Salicylate-sodium—Vomiting—Everolimus—kidney cancer	0.000163	0.000748	CcSEcCtD
Salicylate-sodium—Renal impairment—Doxorubicin—kidney cancer	0.000163	0.000746	CcSEcCtD
Salicylate-sodium—Paraesthesia—Vincristine—kidney cancer	0.000163	0.000746	CcSEcCtD
Salicylate-sodium—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—kidney cancer	0.000162	0.00548	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—SOD2—kidney cancer	0.000162	0.00546	CbGpPWpGaD
Salicylate-sodium—Rash—Everolimus—kidney cancer	0.000162	0.000741	CcSEcCtD
Salicylate-sodium—Dermatitis—Everolimus—kidney cancer	0.000162	0.000741	CcSEcCtD
Salicylate-sodium—Headache—Vinblastine—kidney cancer	0.000161	0.000739	CcSEcCtD
Salicylate-sodium—Headache—Everolimus—kidney cancer	0.000161	0.000737	CcSEcCtD
Salicylate-sodium—Hypotension—Gemcitabine—kidney cancer	0.000161	0.000736	CcSEcCtD
Salicylate-sodium—Abdominal pain—Dactinomycin—kidney cancer	0.00016	0.000735	CcSEcCtD
Salicylate-sodium—Body temperature increased—Dactinomycin—kidney cancer	0.00016	0.000735	CcSEcCtD
Salicylate-sodium—Asthenia—Sorafenib—kidney cancer	0.00016	0.000732	CcSEcCtD
Salicylate-sodium—Syncope—Paclitaxel—kidney cancer	0.000158	0.000725	CcSEcCtD
Salicylate-sodium—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000158	0.000725	CcSEcCtD
Salicylate-sodium—Lethargy—Doxorubicin—kidney cancer	0.000158	0.000725	CcSEcCtD
Salicylate-sodium—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—kidney cancer	0.000158	0.00533	CbGpPWpGaD
Salicylate-sodium—Hypersensitivity—Sunitinib—kidney cancer	0.000158	0.000723	CcSEcCtD
Salicylate-sodium—Decreased appetite—Vincristine—kidney cancer	0.000158	0.000722	CcSEcCtD
Salicylate-sodium—Pruritus—Sorafenib—kidney cancer	0.000158	0.000722	CcSEcCtD
Salicylate-sodium—Vomiting—Erlotinib—kidney cancer	0.000157	0.000721	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Capecitabine—kidney cancer	0.000157	0.00072	CcSEcCtD
Salicylate-sodium—Fatigue—Vincristine—kidney cancer	0.000156	0.000716	CcSEcCtD
Salicylate-sodium—Rash—Erlotinib—kidney cancer	0.000156	0.000715	CcSEcCtD
Salicylate-sodium—Dermatitis—Erlotinib—kidney cancer	0.000156	0.000715	CcSEcCtD
Salicylate-sodium—Palpitations—Paclitaxel—kidney cancer	0.000156	0.000714	CcSEcCtD
Salicylate-sodium—Headache—Erlotinib—kidney cancer	0.000155	0.000711	CcSEcCtD
Salicylate-sodium—Tinnitus—Capecitabine—kidney cancer	0.000155	0.00071	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Paclitaxel—kidney cancer	0.000155	0.00071	CcSEcCtD
Salicylate-sodium—Constipation—Vincristine—kidney cancer	0.000155	0.00071	CcSEcCtD
Salicylate-sodium—Pain—Vincristine—kidney cancer	0.000155	0.00071	CcSEcCtD
Salicylate-sodium—Paraesthesia—Gemcitabine—kidney cancer	0.000154	0.000708	CcSEcCtD
Salicylate-sodium—Asthenia—Sunitinib—kidney cancer	0.000154	0.000705	CcSEcCtD
Salicylate-sodium—Dyspnoea—Gemcitabine—kidney cancer	0.000153	0.000702	CcSEcCtD
Salicylate-sodium—Nausea—Vinblastine—kidney cancer	0.000153	0.000701	CcSEcCtD
Salicylate-sodium—Somnolence—Gemcitabine—kidney cancer	0.000153	0.0007	CcSEcCtD
Salicylate-sodium—Convulsion—Paclitaxel—kidney cancer	0.000153	0.0007	CcSEcCtD
Salicylate-sodium—Nausea—Everolimus—kidney cancer	0.000152	0.000698	CcSEcCtD
Salicylate-sodium—Diarrhoea—Sorafenib—kidney cancer	0.000152	0.000698	CcSEcCtD
Salicylate-sodium—Pruritus—Sunitinib—kidney cancer	0.000152	0.000695	CcSEcCtD
Salicylate-sodium—Chest pain—Paclitaxel—kidney cancer	0.00015	0.000688	CcSEcCtD
Salicylate-sodium—Anxiety—Paclitaxel—kidney cancer	0.00015	0.000686	CcSEcCtD
Salicylate-sodium—Decreased appetite—Gemcitabine—kidney cancer	0.000149	0.000685	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Dactinomycin—kidney cancer	0.000149	0.000685	CcSEcCtD
Salicylate-sodium—Arrhythmia—Capecitabine—kidney cancer	0.000149	0.000681	CcSEcCtD
Salicylate-sodium—Fatigue—Gemcitabine—kidney cancer	0.000148	0.000679	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Vincristine—kidney cancer	0.000148	0.000679	CcSEcCtD
Salicylate-sodium—PTGS1—Biological oxidations—GSTT1—kidney cancer	0.000148	0.00499	CbGpPWpGaD
Salicylate-sodium—Dizziness—Sorafenib—kidney cancer	0.000147	0.000675	CcSEcCtD
Salicylate-sodium—Pain—Gemcitabine—kidney cancer	0.000147	0.000674	CcSEcCtD
Salicylate-sodium—Constipation—Gemcitabine—kidney cancer	0.000147	0.000674	CcSEcCtD
Salicylate-sodium—Nausea—Erlotinib—kidney cancer	0.000147	0.000674	CcSEcCtD
Salicylate-sodium—Diarrhoea—Sunitinib—kidney cancer	0.000147	0.000672	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—ANXA1—kidney cancer	0.000146	0.00493	CbGpPWpGaD
Salicylate-sodium—Asthenia—Dactinomycin—kidney cancer	0.000146	0.000667	CcSEcCtD
Salicylate-sodium—Confusional state—Paclitaxel—kidney cancer	0.000145	0.000665	CcSEcCtD
Salicylate-sodium—Blood creatinine increased—Doxorubicin—kidney cancer	0.000145	0.000665	CcSEcCtD
Salicylate-sodium—Erythema—Capecitabine—kidney cancer	0.000145	0.000663	CcSEcCtD
Salicylate-sodium—Dehydration—Doxorubicin—kidney cancer	0.000144	0.00066	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Paclitaxel—kidney cancer	0.000144	0.00066	CcSEcCtD
Salicylate-sodium—Oedema—Paclitaxel—kidney cancer	0.000144	0.00066	CcSEcCtD
Salicylate-sodium—Abdominal pain—Vincristine—kidney cancer	0.000143	0.000657	CcSEcCtD
Salicylate-sodium—Body temperature increased—Vincristine—kidney cancer	0.000143	0.000657	CcSEcCtD
Salicylate-sodium—Infection—Paclitaxel—kidney cancer	0.000143	0.000655	CcSEcCtD
Salicylate-sodium—PTGS1—Arachidonic acid metabolism—PTGS2—kidney cancer	0.000143	0.00482	CbGpPWpGaD
Salicylate-sodium—Flatulence—Capecitabine—kidney cancer	0.000143	0.000654	CcSEcCtD
Salicylate-sodium—Dysgeusia—Capecitabine—kidney cancer	0.000142	0.00065	CcSEcCtD
Salicylate-sodium—Dizziness—Sunitinib—kidney cancer	0.000142	0.000649	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Gemcitabine—kidney cancer	0.000142	0.000649	CcSEcCtD
Salicylate-sodium—Shock—Paclitaxel—kidney cancer	0.000142	0.000649	CcSEcCtD
Salicylate-sodium—Vomiting—Sorafenib—kidney cancer	0.000142	0.000649	CcSEcCtD
Salicylate-sodium—Abdominal pain upper—Doxorubicin—kidney cancer	0.000141	0.000648	CcSEcCtD
Salicylate-sodium—Hypokalaemia—Doxorubicin—kidney cancer	0.000141	0.000646	CcSEcCtD
Salicylate-sodium—Tachycardia—Paclitaxel—kidney cancer	0.00014	0.000644	CcSEcCtD
Salicylate-sodium—Rash—Sorafenib—kidney cancer	0.00014	0.000643	CcSEcCtD
Salicylate-sodium—Dermatitis—Sorafenib—kidney cancer	0.00014	0.000643	CcSEcCtD
Salicylate-sodium—Headache—Sorafenib—kidney cancer	0.000139	0.000639	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Paclitaxel—kidney cancer	0.000139	0.000638	CcSEcCtD
Salicylate-sodium—Diarrhoea—Dactinomycin—kidney cancer	0.000139	0.000636	CcSEcCtD
Salicylate-sodium—Anorexia—Paclitaxel—kidney cancer	0.000137	0.000629	CcSEcCtD
Salicylate-sodium—Vision blurred—Capecitabine—kidney cancer	0.000136	0.000625	CcSEcCtD
Salicylate-sodium—Vomiting—Sunitinib—kidney cancer	0.000136	0.000624	CcSEcCtD
Salicylate-sodium—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—kidney cancer	0.000136	0.00459	CbGpPWpGaD
Salicylate-sodium—Body temperature increased—Gemcitabine—kidney cancer	0.000136	0.000623	CcSEcCtD
Salicylate-sodium—Rash—Sunitinib—kidney cancer	0.000135	0.000619	CcSEcCtD
Salicylate-sodium—Dermatitis—Sunitinib—kidney cancer	0.000135	0.000619	CcSEcCtD
Salicylate-sodium—Abdominal distension—Doxorubicin—kidney cancer	0.000135	0.000618	CcSEcCtD
Salicylate-sodium—Hypotension—Paclitaxel—kidney cancer	0.000135	0.000616	CcSEcCtD
Salicylate-sodium—Headache—Sunitinib—kidney cancer	0.000134	0.000615	CcSEcCtD
Salicylate-sodium—Asthma—Doxorubicin—kidney cancer	0.000134	0.000614	CcSEcCtD
Salicylate-sodium—Dysphagia—Doxorubicin—kidney cancer	0.000134	0.000614	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Vincristine—kidney cancer	0.000134	0.000612	CcSEcCtD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—GSTM1—kidney cancer	0.000133	0.00448	CbGpPWpGaD
Salicylate-sodium—Nausea—Sorafenib—kidney cancer	0.000132	0.000606	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	0.000131	0.00442	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	0.000131	0.00442	CbGpPWpGaD
Salicylate-sodium—Asthenia—Vincristine—kidney cancer	0.00013	0.000596	CcSEcCtD
Salicylate-sodium—Syncope—Capecitabine—kidney cancer	0.00013	0.000595	CcSEcCtD
Salicylate-sodium—Paraesthesia—Paclitaxel—kidney cancer	0.000129	0.000592	CcSEcCtD
Salicylate-sodium—Vomiting—Dactinomycin—kidney cancer	0.000129	0.000591	CcSEcCtD
Salicylate-sodium—Bronchitis—Doxorubicin—kidney cancer	0.000129	0.00059	CcSEcCtD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—SOD2—kidney cancer	0.000128	0.00433	CbGpPWpGaD
Salicylate-sodium—Dyspnoea—Paclitaxel—kidney cancer	0.000128	0.000588	CcSEcCtD
Salicylate-sodium—Somnolence—Paclitaxel—kidney cancer	0.000128	0.000586	CcSEcCtD
Salicylate-sodium—Palpitations—Capecitabine—kidney cancer	0.000128	0.000586	CcSEcCtD
Salicylate-sodium—Rash—Dactinomycin—kidney cancer	0.000128	0.000586	CcSEcCtD
Salicylate-sodium—Nausea—Sunitinib—kidney cancer	0.000127	0.000583	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Capecitabine—kidney cancer	0.000127	0.000583	CcSEcCtD
Salicylate-sodium—Dyspepsia—Paclitaxel—kidney cancer	0.000127	0.000581	CcSEcCtD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000125	0.00423	CbGpPWpGaD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	0.000125	0.00423	CbGpPWpGaD
Salicylate-sodium—Decreased appetite—Paclitaxel—kidney cancer	0.000125	0.000573	CcSEcCtD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—RELA—kidney cancer	0.000125	0.00421	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	0.000124	0.00419	CbGpPWpGaD
Salicylate-sodium—Fatigue—Paclitaxel—kidney cancer	0.000124	0.000569	CcSEcCtD
Salicylate-sodium—Diarrhoea—Vincristine—kidney cancer	0.000124	0.000568	CcSEcCtD
Salicylate-sodium—Asthenia—Gemcitabine—kidney cancer	0.000123	0.000565	CcSEcCtD
Salicylate-sodium—Chest pain—Capecitabine—kidney cancer	0.000123	0.000565	CcSEcCtD
Salicylate-sodium—Constipation—Paclitaxel—kidney cancer	0.000123	0.000564	CcSEcCtD
Salicylate-sodium—Pain—Paclitaxel—kidney cancer	0.000123	0.000564	CcSEcCtD
Salicylate-sodium—Anxiety—Capecitabine—kidney cancer	0.000123	0.000563	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—EGR1—kidney cancer	0.000123	0.00414	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000122	0.00413	CbGpPWpGaD
Salicylate-sodium—Weight increased—Doxorubicin—kidney cancer	0.000122	0.000558	CcSEcCtD
Salicylate-sodium—Pruritus—Gemcitabine—kidney cancer	0.000122	0.000557	CcSEcCtD
Salicylate-sodium—Nausea—Dactinomycin—kidney cancer	0.00012	0.000552	CcSEcCtD
Salicylate-sodium—Dizziness—Vincristine—kidney cancer	0.00012	0.000549	CcSEcCtD
Salicylate-sodium—Drowsiness—Doxorubicin—kidney cancer	0.000119	0.000547	CcSEcCtD
Salicylate-sodium—Confusional state—Capecitabine—kidney cancer	0.000119	0.000546	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Paclitaxel—kidney cancer	0.000119	0.000544	CcSEcCtD
Salicylate-sodium—Oedema—Capecitabine—kidney cancer	0.000118	0.000541	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000118	0.000539	CcSEcCtD
Salicylate-sodium—Diarrhoea—Gemcitabine—kidney cancer	0.000118	0.000539	CcSEcCtD
Salicylate-sodium—Renal failure—Doxorubicin—kidney cancer	0.000117	0.000538	CcSEcCtD
Salicylate-sodium—Infection—Capecitabine—kidney cancer	0.000117	0.000538	CcSEcCtD
Salicylate-sodium—Shock—Capecitabine—kidney cancer	0.000116	0.000533	CcSEcCtD
Salicylate-sodium—Tachycardia—Capecitabine—kidney cancer	0.000115	0.000528	CcSEcCtD
Salicylate-sodium—Vomiting—Vincristine—kidney cancer	0.000115	0.000528	CcSEcCtD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	0.000115	0.00387	CbGpPWpGaD
Salicylate-sodium—Urticaria—Paclitaxel—kidney cancer	0.000114	0.000524	CcSEcCtD
Salicylate-sodium—Rash—Vincristine—kidney cancer	0.000114	0.000524	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Capecitabine—kidney cancer	0.000114	0.000523	CcSEcCtD
Salicylate-sodium—Dermatitis—Vincristine—kidney cancer	0.000114	0.000523	CcSEcCtD
Salicylate-sodium—Abdominal pain—Paclitaxel—kidney cancer	0.000114	0.000522	CcSEcCtD
Salicylate-sodium—Body temperature increased—Paclitaxel—kidney cancer	0.000114	0.000522	CcSEcCtD
Salicylate-sodium—Headache—Vincristine—kidney cancer	0.000114	0.00052	CcSEcCtD
Salicylate-sodium—Epistaxis—Doxorubicin—kidney cancer	0.000113	0.000516	CcSEcCtD
Salicylate-sodium—Anorexia—Capecitabine—kidney cancer	0.000113	0.000516	CcSEcCtD
Salicylate-sodium—Hypotension—Capecitabine—kidney cancer	0.00011	0.000506	CcSEcCtD
Salicylate-sodium—Vomiting—Gemcitabine—kidney cancer	0.000109	0.000501	CcSEcCtD
Salicylate-sodium—Rash—Gemcitabine—kidney cancer	0.000108	0.000497	CcSEcCtD
Salicylate-sodium—Dermatitis—Gemcitabine—kidney cancer	0.000108	0.000496	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	0.000108	0.00365	CbGpPWpGaD
Salicylate-sodium—Headache—Gemcitabine—kidney cancer	0.000108	0.000494	CcSEcCtD
Salicylate-sodium—Nausea—Vincristine—kidney cancer	0.000108	0.000493	CcSEcCtD
Salicylate-sodium—Hepatitis—Doxorubicin—kidney cancer	0.000107	0.000491	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Doxorubicin—kidney cancer	0.000107	0.000489	CcSEcCtD
Salicylate-sodium—Paraesthesia—Capecitabine—kidney cancer	0.000106	0.000486	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Paclitaxel—kidney cancer	0.000106	0.000486	CcSEcCtD
Salicylate-sodium—Dyspnoea—Capecitabine—kidney cancer	0.000105	0.000483	CcSEcCtD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—kidney cancer	0.000105	0.00355	CbGpPWpGaD
Salicylate-sodium—Dyspepsia—Capecitabine—kidney cancer	0.000104	0.000477	CcSEcCtD
Salicylate-sodium—Asthenia—Paclitaxel—kidney cancer	0.000103	0.000473	CcSEcCtD
Salicylate-sodium—Decreased appetite—Capecitabine—kidney cancer	0.000103	0.000471	CcSEcCtD
Salicylate-sodium—PTGS1—Biological oxidations—GSTP1—kidney cancer	0.000103	0.00346	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—kidney cancer	0.000102	0.00345	CbGpPWpGaD
Salicylate-sodium—Nausea—Gemcitabine—kidney cancer	0.000102	0.000468	CcSEcCtD
Salicylate-sodium—Fatigue—Capecitabine—kidney cancer	0.000102	0.000467	CcSEcCtD
Salicylate-sodium—Pruritus—Paclitaxel—kidney cancer	0.000102	0.000467	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Doxorubicin—kidney cancer	0.000101	0.000464	CcSEcCtD
Salicylate-sodium—Pain—Capecitabine—kidney cancer	0.000101	0.000463	CcSEcCtD
Salicylate-sodium—Constipation—Capecitabine—kidney cancer	0.000101	0.000463	CcSEcCtD
Salicylate-sodium—Tinnitus—Doxorubicin—kidney cancer	9.99e-05	0.000458	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	9.93e-05	0.00335	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—KIT—kidney cancer	9.86e-05	0.00333	CbGpPWpGaD
Salicylate-sodium—Diarrhoea—Paclitaxel—kidney cancer	9.85e-05	0.000451	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Capecitabine—kidney cancer	9.73e-05	0.000446	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	9.71e-05	0.00328	CbGpPWpGaD
Salicylate-sodium—Gastrointestinal pain—Capecitabine—kidney cancer	9.66e-05	0.000443	CcSEcCtD
Salicylate-sodium—Arrhythmia—Doxorubicin—kidney cancer	9.57e-05	0.000439	CcSEcCtD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	9.55e-05	0.00322	CbGpPWpGaD
Salicylate-sodium—Dizziness—Paclitaxel—kidney cancer	9.52e-05	0.000436	CcSEcCtD
Salicylate-sodium—PTGS1—Biological oxidations—GSTM1—kidney cancer	9.43e-05	0.00318	CbGpPWpGaD
Salicylate-sodium—Urticaria—Capecitabine—kidney cancer	9.38e-05	0.00043	CcSEcCtD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—RELA—kidney cancer	9.35e-05	0.00316	CbGpPWpGaD
Salicylate-sodium—Body temperature increased—Capecitabine—kidney cancer	9.34e-05	0.000428	CcSEcCtD
Salicylate-sodium—Abdominal pain—Capecitabine—kidney cancer	9.34e-05	0.000428	CcSEcCtD
Salicylate-sodium—Erythema—Doxorubicin—kidney cancer	9.33e-05	0.000428	CcSEcCtD
Salicylate-sodium—Flatulence—Doxorubicin—kidney cancer	9.19e-05	0.000421	CcSEcCtD
Salicylate-sodium—Vomiting—Paclitaxel—kidney cancer	9.15e-05	0.000419	CcSEcCtD
Salicylate-sodium—Dysgeusia—Doxorubicin—kidney cancer	9.14e-05	0.000419	CcSEcCtD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—PTGS2—kidney cancer	9.09e-05	0.00307	CbGpPWpGaD
Salicylate-sodium—Rash—Paclitaxel—kidney cancer	9.08e-05	0.000416	CcSEcCtD
Salicylate-sodium—Dermatitis—Paclitaxel—kidney cancer	9.07e-05	0.000416	CcSEcCtD
Salicylate-sodium—Headache—Paclitaxel—kidney cancer	9.02e-05	0.000413	CcSEcCtD
Salicylate-sodium—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—kidney cancer	8.98e-05	0.00303	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—CYP1A1—kidney cancer	8.94e-05	0.00302	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	8.91e-05	0.00301	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	8.91e-05	0.00301	CbGpPWpGaD
Salicylate-sodium—Vision blurred—Doxorubicin—kidney cancer	8.79e-05	0.000403	CcSEcCtD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	8.78e-05	0.00296	CbGpPWpGaD
Salicylate-sodium—Hypersensitivity—Capecitabine—kidney cancer	8.7e-05	0.000399	CcSEcCtD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	8.59e-05	0.0029	CbGpPWpGaD
Salicylate-sodium—Nausea—Paclitaxel—kidney cancer	8.55e-05	0.000392	CcSEcCtD
Salicylate-sodium—Asthenia—Capecitabine—kidney cancer	8.48e-05	0.000388	CcSEcCtD
Salicylate-sodium—Syncope—Doxorubicin—kidney cancer	8.37e-05	0.000383	CcSEcCtD
Salicylate-sodium—Pruritus—Capecitabine—kidney cancer	8.36e-05	0.000383	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	8.34e-05	0.00281	CbGpPWpGaD
Salicylate-sodium—Palpitations—Doxorubicin—kidney cancer	8.24e-05	0.000378	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Doxorubicin—kidney cancer	8.2e-05	0.000376	CcSEcCtD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	8.12e-05	0.00274	CbGpPWpGaD
Salicylate-sodium—Convulsion—Doxorubicin—kidney cancer	8.08e-05	0.00037	CcSEcCtD
Salicylate-sodium—Diarrhoea—Capecitabine—kidney cancer	8.08e-05	0.00037	CcSEcCtD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—CDKN2A—kidney cancer	8.01e-05	0.0027	CbGpPWpGaD
Salicylate-sodium—Chest pain—Doxorubicin—kidney cancer	7.94e-05	0.000364	CcSEcCtD
Salicylate-sodium—Anxiety—Doxorubicin—kidney cancer	7.92e-05	0.000363	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—ACY1—kidney cancer	7.86e-05	0.00265	CbGpPWpGaD
Salicylate-sodium—Dizziness—Capecitabine—kidney cancer	7.81e-05	0.000358	CcSEcCtD
Salicylate-sodium—Confusional state—Doxorubicin—kidney cancer	7.68e-05	0.000352	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Doxorubicin—kidney cancer	7.61e-05	0.000349	CcSEcCtD
Salicylate-sodium—Oedema—Doxorubicin—kidney cancer	7.61e-05	0.000349	CcSEcCtD
Salicylate-sodium—Infection—Doxorubicin—kidney cancer	7.56e-05	0.000347	CcSEcCtD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—CD4—kidney cancer	7.54e-05	0.00254	CbGpPWpGaD
Salicylate-sodium—Vomiting—Capecitabine—kidney cancer	7.51e-05	0.000344	CcSEcCtD
Salicylate-sodium—Shock—Doxorubicin—kidney cancer	7.49e-05	0.000343	CcSEcCtD
Salicylate-sodium—Rash—Capecitabine—kidney cancer	7.45e-05	0.000341	CcSEcCtD
Salicylate-sodium—Dermatitis—Capecitabine—kidney cancer	7.44e-05	0.000341	CcSEcCtD
Salicylate-sodium—Tachycardia—Doxorubicin—kidney cancer	7.43e-05	0.000341	CcSEcCtD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—RELA—kidney cancer	7.42e-05	0.0025	CbGpPWpGaD
Salicylate-sodium—Headache—Capecitabine—kidney cancer	7.4e-05	0.000339	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Doxorubicin—kidney cancer	7.36e-05	0.000337	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	7.32e-05	0.00247	CbGpPWpGaD
Salicylate-sodium—Anorexia—Doxorubicin—kidney cancer	7.26e-05	0.000333	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	7.26e-05	0.00245	CbGpPWpGaD
Salicylate-sodium—Hypotension—Doxorubicin—kidney cancer	7.12e-05	0.000326	CcSEcCtD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—CDKN1B—kidney cancer	7.09e-05	0.00239	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	7.09e-05	0.00239	CbGpPWpGaD
Salicylate-sodium—Nausea—Capecitabine—kidney cancer	7.02e-05	0.000322	CcSEcCtD
Salicylate-sodium—Paraesthesia—Doxorubicin—kidney cancer	6.84e-05	0.000313	CcSEcCtD
Salicylate-sodium—Dyspnoea—Doxorubicin—kidney cancer	6.79e-05	0.000311	CcSEcCtD
Salicylate-sodium—Somnolence—Doxorubicin—kidney cancer	6.77e-05	0.00031	CcSEcCtD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—CCND1—kidney cancer	6.76e-05	0.00228	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	6.7e-05	0.00226	CbGpPWpGaD
Salicylate-sodium—Dyspepsia—Doxorubicin—kidney cancer	6.7e-05	0.000307	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—PDHB—kidney cancer	6.68e-05	0.00226	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—POMC—kidney cancer	6.66e-05	0.00225	CbGpPWpGaD
Salicylate-sodium—Decreased appetite—Doxorubicin—kidney cancer	6.62e-05	0.000303	CcSEcCtD
Salicylate-sodium—Fatigue—Doxorubicin—kidney cancer	6.56e-05	0.000301	CcSEcCtD
Salicylate-sodium—Constipation—Doxorubicin—kidney cancer	6.51e-05	0.000298	CcSEcCtD
Salicylate-sodium—Pain—Doxorubicin—kidney cancer	6.51e-05	0.000298	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—CCBL1—kidney cancer	6.28e-05	0.00212	CbGpPWpGaD
Salicylate-sodium—Feeling abnormal—Doxorubicin—kidney cancer	6.27e-05	0.000288	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—ACY1—kidney cancer	6.24e-05	0.00211	CbGpPWpGaD
Salicylate-sodium—Gastrointestinal pain—Doxorubicin—kidney cancer	6.23e-05	0.000285	CcSEcCtD
Salicylate-sodium—Urticaria—Doxorubicin—kidney cancer	6.05e-05	0.000277	CcSEcCtD
Salicylate-sodium—Body temperature increased—Doxorubicin—kidney cancer	6.02e-05	0.000276	CcSEcCtD
Salicylate-sodium—Abdominal pain—Doxorubicin—kidney cancer	6.02e-05	0.000276	CcSEcCtD
Salicylate-sodium—PTGS2—Disease—CCBL1—kidney cancer	5.96e-05	0.00201	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	5.68e-05	0.00192	CbGpPWpGaD
Salicylate-sodium—Hypersensitivity—Doxorubicin—kidney cancer	5.61e-05	0.000257	CcSEcCtD
Salicylate-sodium—Asthenia—Doxorubicin—kidney cancer	5.46e-05	0.00025	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—GLIPR1—kidney cancer	5.45e-05	0.00184	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PPAT—kidney cancer	5.45e-05	0.00184	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—MYC—kidney cancer	5.43e-05	0.00183	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—CDKN1B—kidney cancer	5.4e-05	0.00182	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—AMER1—kidney cancer	5.39e-05	0.00182	CbGpPWpGaD
Salicylate-sodium—Pruritus—Doxorubicin—kidney cancer	5.39e-05	0.000247	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	5.38e-05	0.00182	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	5.32e-05	0.0018	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PDHB—kidney cancer	5.31e-05	0.00179	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IL2—kidney cancer	5.29e-05	0.00178	CbGpPWpGaD
Salicylate-sodium—Diarrhoea—Doxorubicin—kidney cancer	5.21e-05	0.000239	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—CCND1—kidney cancer	5.15e-05	0.00174	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	5.11e-05	0.00172	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—APRT—kidney cancer	5.07e-05	0.00171	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—FH—kidney cancer	5.07e-05	0.00171	CbGpPWpGaD
Salicylate-sodium—Dizziness—Doxorubicin—kidney cancer	5.04e-05	0.000231	CcSEcCtD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—KRAS—kidney cancer	5.01e-05	0.00169	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CCBL1—kidney cancer	4.99e-05	0.00168	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.95e-05	0.00167	CbGpPWpGaD
Salicylate-sodium—Vomiting—Doxorubicin—kidney cancer	4.84e-05	0.000222	CcSEcCtD
Salicylate-sodium—Rash—Doxorubicin—kidney cancer	4.8e-05	0.00022	CcSEcCtD
Salicylate-sodium—Dermatitis—Doxorubicin—kidney cancer	4.8e-05	0.00022	CcSEcCtD
Salicylate-sodium—Headache—Doxorubicin—kidney cancer	4.77e-05	0.000219	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—GPC3—kidney cancer	4.76e-05	0.00161	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CA2—kidney cancer	4.63e-05	0.00156	CbGpPWpGaD
Salicylate-sodium—Nausea—Doxorubicin—kidney cancer	4.52e-05	0.000207	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—ALAD—kidney cancer	4.52e-05	0.00152	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—GPC3—kidney cancer	4.51e-05	0.00152	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.51e-05	0.00152	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ST3GAL2—kidney cancer	4.41e-05	0.00149	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GLIPR1—kidney cancer	4.33e-05	0.00146	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PPAT—kidney cancer	4.33e-05	0.00146	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ALDH1A1—kidney cancer	4.31e-05	0.00145	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.27e-05	0.00144	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—MAPK3—kidney cancer	4.25e-05	0.00143	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.23e-05	0.00143	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ST3GAL2—kidney cancer	4.18e-05	0.00141	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—MYC—kidney cancer	4.13e-05	0.00139	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PGK1—kidney cancer	4.13e-05	0.00139	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—SLC5A3—kidney cancer	4.13e-05	0.00139	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—LDHB—kidney cancer	4.05e-05	0.00137	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—MAPK1—kidney cancer	4.04e-05	0.00136	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—FH—kidney cancer	4.02e-05	0.00136	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—APRT—kidney cancer	4.02e-05	0.00136	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	4.01e-05	0.00135	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	3.97e-05	0.00134	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.93e-05	0.00133	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PGK1—kidney cancer	3.91e-05	0.00132	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—SLC5A3—kidney cancer	3.91e-05	0.00132	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—LDHB—kidney cancer	3.84e-05	0.0013	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—SFRP2—kidney cancer	3.84e-05	0.0013	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GPC3—kidney cancer	3.78e-05	0.00128	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CA2—kidney cancer	3.68e-05	0.00124	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	3.67e-05	0.00124	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ALAD—kidney cancer	3.58e-05	0.00121	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—TCEB2—kidney cancer	3.58e-05	0.00121	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—TCEB1—kidney cancer	3.58e-05	0.00121	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CA9—kidney cancer	3.51e-05	0.00118	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	3.51e-05	0.00118	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ST3GAL2—kidney cancer	3.5e-05	0.00118	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	3.5e-05	0.00118	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	3.47e-05	0.00117	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.43e-05	0.00116	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ALDH1A1—kidney cancer	3.42e-05	0.00115	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TP53—kidney cancer	3.39e-05	0.00115	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	3.38e-05	0.00114	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SLC5A3—kidney cancer	3.28e-05	0.00111	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PGK1—kidney cancer	3.28e-05	0.00111	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—LDHB—kidney cancer	3.21e-05	0.00108	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	3.06e-05	0.00103	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CRABP1—kidney cancer	2.99e-05	0.00101	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—RPL14—kidney cancer	2.91e-05	0.000982	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.89e-05	0.000976	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.81e-05	0.000949	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CA9—kidney cancer	2.79e-05	0.000941	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ITPR2—kidney cancer	2.78e-05	0.000937	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.75e-05	0.000928	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.72e-05	0.000919	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ITPR2—kidney cancer	2.63e-05	0.000888	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.6e-05	0.000877	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.56e-05	0.000863	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTT1—kidney cancer	2.53e-05	0.000854	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ACHE—kidney cancer	2.53e-05	0.000854	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—SCARB1—kidney cancer	2.4e-05	0.000809	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.39e-05	0.000806	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CRABP1—kidney cancer	2.37e-05	0.0008	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PSMD7—kidney cancer	2.33e-05	0.000785	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.31e-05	0.000779	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—BCHE—kidney cancer	2.21e-05	0.000744	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PSMD7—kidney cancer	2.2e-05	0.000744	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ITPR2—kidney cancer	2.2e-05	0.000744	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—SLC5A5—kidney cancer	2.18e-05	0.000735	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—SLC2A1—kidney cancer	2.1e-05	0.00071	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.04e-05	0.000689	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.03e-05	0.000685	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTT1—kidney cancer	2.01e-05	0.000678	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ACHE—kidney cancer	2.01e-05	0.000678	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—SLC2A1—kidney cancer	1.99e-05	0.000673	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—JUNB—kidney cancer	1.98e-05	0.000668	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SCARB1—kidney cancer	1.9e-05	0.000642	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PTGS1—kidney cancer	1.88e-05	0.000635	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PSMD7—kidney cancer	1.85e-05	0.000623	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.78e-05	0.000601	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTP1—kidney cancer	1.75e-05	0.000592	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—BCHE—kidney cancer	1.75e-05	0.000591	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SLC5A5—kidney cancer	1.73e-05	0.000583	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SLC2A1—kidney cancer	1.67e-05	0.000564	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ABCB1—kidney cancer	1.66e-05	0.00056	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTM1—kidney cancer	1.61e-05	0.000544	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CDKN2B—kidney cancer	1.61e-05	0.000544	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP1A1—kidney cancer	1.53e-05	0.000516	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.41e-05	0.000477	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTP1—kidney cancer	1.39e-05	0.00047	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ABCB1—kidney cancer	1.32e-05	0.000445	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HIF1A—kidney cancer	1.29e-05	0.000435	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—TSC2—kidney cancer	1.28e-05	0.000434	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTM1—kidney cancer	1.28e-05	0.000432	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.26e-05	0.000424	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP1A1—kidney cancer	1.21e-05	0.000409	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—POMC—kidney cancer	1.14e-05	0.000385	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—KIT—kidney cancer	1.13e-05	0.000383	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—APC—kidney cancer	1.13e-05	0.000383	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—BRAF—kidney cancer	1.07e-05	0.00036	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.97e-06	0.000336	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PTGS2—kidney cancer	9.09e-06	0.000307	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—POMC—kidney cancer	9.05e-06	0.000305	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—RAF1—kidney cancer	8.91e-06	0.000301	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ERBB2—kidney cancer	8.81e-06	0.000297	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MTOR—kidney cancer	8.7e-06	0.000293	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CD4—kidney cancer	8.68e-06	0.000293	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CDKN1B—kidney cancer	8.16e-06	0.000275	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PTEN—kidney cancer	7.93e-06	0.000267	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CTNNB1—kidney cancer	7.71e-06	0.00026	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PTEN—kidney cancer	7.51e-06	0.000254	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MAPK3—kidney cancer	6.42e-06	0.000217	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PTEN—kidney cancer	6.29e-06	0.000212	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MYC—kidney cancer	6.24e-06	0.000211	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MAPK1—kidney cancer	6.11e-06	0.000206	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—KRAS—kidney cancer	5.77e-06	0.000195	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PIK3CA—kidney cancer	5.59e-06	0.000189	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PIK3CA—kidney cancer	5.3e-06	0.000179	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PIK3CA—kidney cancer	4.44e-06	0.00015	CbGpPWpGaD
